Anti-ZDH20/ ZDHHC20/ 4933421L13Rik monoclonal antibody

Anti-ZDH20/ ZDHHC20/ 4933421L13Rik antibody for FACS & in-vivo assay

Target products collectionGo to ZDHHC20/ZDHHC20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1957-Ab-1/ GM-Tg-hg-MP1957-Ab-2Anti-Human ZDHHC20 monoclonal antibodyHuman
GM-Tg-rg-MP1957-Ab-1/ GM-Tg-rg-MP1957-Ab-2Anti-Rat ZDHHC20 monoclonal antibodyRat
GM-Tg-mg-MP1957-Ab-1/ GM-Tg-mg-MP1957-Ab-2Anti-Mouse ZDHHC20 monoclonal antibodyMouse
GM-Tg-cynog-MP1957-Ab-1/ GM-Tg-cynog-MP1957-Ab-2Anti-Cynomolgus/ Rhesus macaque ZDHHC20 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1957-Ab-1/ GM-Tg-felg-MP1957-Ab-2Anti-Feline ZDHHC20 monoclonal antibodyFeline
GM-Tg-cang-MP1957-Ab-1/ GM-Tg-cang-MP1957-Ab-2Anti-Canine ZDHHC20 monoclonal antibodyCanine
GM-Tg-bovg-MP1957-Ab-1/ GM-Tg-bovg-MP1957-Ab-2Anti-Bovine ZDHHC20 monoclonal antibodyBovine
GM-Tg-equg-MP1957-Ab-1/ GM-Tg-equg-MP1957-Ab-2Anti-Equine ZDHHC20 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1957-Ab-1/ GM-Tg-hg-MP1957-Ab-2; GM-Tg-rg-MP1957-Ab-1/ GM-Tg-rg-MP1957-Ab-2;
GM-Tg-mg-MP1957-Ab-1/ GM-Tg-mg-MP1957-Ab-2; GM-Tg-cynog-MP1957-Ab-1/ GM-Tg-cynog-MP1957-Ab-2;
GM-Tg-felg-MP1957-Ab-1/ GM-Tg-felg-MP1957-Ab-2; GM-Tg-cang-MP1957-Ab-1/ GM-Tg-cang-MP1957-Ab-2;
GM-Tg-bovg-MP1957-Ab-1/ GM-Tg-bovg-MP1957-Ab-2; GM-Tg-equg-MP1957-Ab-1/ GM-Tg-equg-MP1957-Ab-2
Products NameAnti-ZDHHC20 monoclonal antibody
Formatmab
Target NameZDHHC20
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ZDHHC20 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ZDH20/ ZDHHC20/ 4933421L13Rik VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1957
    Target NameZDHHC20
    Gene ID253832,75965,305923,705802,486045,101084079,615659,100055368
    Gene Symbol and Synonyms4930542A17Rik,4933421L13Rik,5033406L14Rik,B230110O18Rik,DHHC-20,DHHC20,HK11,RGD1305755,ZDHHC20
    Uniprot AccessionQ5W0Z9,Q0VC89
    Uniprot Entry NameZDH20_HUMAN,ZDH20_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000180776
    Target ClassificationN/A

    The target: ZDHHC20, gene name: ZDHHC20, also named as 4933421L13Rik, DHHC-20, DHHC20. Enables protein-cysteine S-palmitoyltransferase activity and zinc ion binding activity. Involved in peptidyl-L-cysteine S-palmitoylation. Located in intracellular membrane-bounded organelle and plasma membrane. Is integral component of Golgi membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.